Welcome to CDC stacks | Supporting Human Papillomavirus Vaccination in Adolescents: Perspectives from Commercial and Medicaid Health Plans - 44897 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Supporting Human Papillomavirus Vaccination in Adolescents: Perspectives from Commercial and Medicaid Health Plans
  • Published Date:
    2017 May/Jun
  • Source:
    J Public Health Manag Pract. 23(3):283-290.
Filetype[PDF-79.88 KB]


Details:
  • Pubmed ID:
    27798527
  • Pubmed Central ID:
    PMC5374051
  • Description:
    Context

    An estimated 79 million Americans are infected with human papillomavirus (HPV). Vaccination can reduce the burden of infection and HPV-associated cancers, yet vaccination rates remain low. Little is known about why some health plans achieve higher vaccination rates.

    Objective

    This study sought to identify strategies used by higher-performing health plans to support HPV vaccination.

    Design

    We used 2013 data from the Health Effectiveness Data and Information Set (HEDIS®) Human Papillomavirus Vaccine for Female Adolescents measure to identify high-performing plans. The measure examines the percentage of female adolescent plan members who received three doses of HPV vaccine by their 13th birthday. High performers were defined as the subset of commercial plans with the top 10 rates and the subset of Medicaid plans with the top 10 rates. An interview guide was developed to assess activities related to providing HPV vaccination. Interviews were conducted with selected plans and audio-recorded. Transcripts were reviewed independently by two interviewers and analyzed by hand to identify key themes.

    Participants

    Ten plans agreed to be interviewed, representing a diversity of plan size (range: 5,500 members to over 2.7 million members); plan type (about half were commercial, half were Medicaid plans); patient population, from predominantly White to predominantly non-White; and geographic region.

    Results

    Plans highlighted multiple strategies that support HPV vaccination, particularly the “normalizing” of the vaccine. Plans’ efforts highlighted patient and provider education, reminders, feedback loops, community collaborations, immunization registries and use of medical home concepts—including team-driven efforts and coordination.

    Conclusions

    Although HPV immunization rates are low nationally, health plans can employ multiple efforts to encourage vaccination by implementing activities that involve the patient, provider and community.

  • Document Type:
  • Collection(s):
  • Place as Subject:
  • Main Document Checksum:
No Related Documents.
You May Also Like: